Lithium and the renal response to gludopa, fenoldopam and dopamine.
Girbes
A R
AR
Smit
A J
AJ
Meijer
S
S
Reitsma
W D
WD
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology*; D004347:Drug Interactions; D018818:Fenoldopam; D006801:Humans; D007687:Kidney Tubules, Proximal / Q000187:drug effects*; D008094:Lithium / Q000494:pharmacology*; D009318:Natriuresis / Q000187:drug effects; D011954:Receptors, Dopamine / Q000378:metabolism
D015259:Dopamine Agents; D011954:Receptors, Dopamine; C017342:gamma-glutamyl DOPA; D004295:Dihydroxyphenylalanine; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D008094:Lithium; D018818:Fenoldopam; D004298:Dopamine